• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.48% Nasdaq Up 0.29%

    Celgene Corporation (CELG)

    -NasdaqGS
    105.52 Down 0.91(0.86%) 4:00PM EDT
    |After Hours : 105.70 Up 0.18 (0.17%) 7:51PM EDT
    Prev Close:106.43
    Open:106.45
    Bid:105.55 x 100
    Ask:105.85 x 100
    1y Target Est:136.82
    Beta:1.61363
    Earnings Date:Jul 21 - Jul 25 (Est.)
    Day's Range:105.42 - 107.44
    52wk Range:92.98 - 140.72
    Volume:5,944,032
    Avg Vol (3m):4,734,350
    Market Cap:81.74B
    P/E (ttm):51.32
    EPS (ttm):2.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CELGDown 0.86%81.74B
    JNJDown 0.33%309.97B

    Key Statistics

    Forward P/E (1 yr):15.07
    P/S (ttm):8.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :5.67
    Quarterly EPS Est (Jun-16) :1.38
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.85

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell ly... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback